SEARCH

SEARCH BY CITATION

References

  • 1
    Davies S, Westin A, Castberg I et al. Characterization of zuclopenthixol metabolism by in vitro and therapeutic drug monitoring studies. Acta Psychiatr Scand 2010;122:444453.
  • 2
    Stahl SM. Stahls essential psychopharmacology prescribers guide: zuclopenthixol, 3rd edn. New York: Cambridge University Press, 2009:613617.
  • 3
    Stahl SM. Stahls essential psychopharmacology prescribers guide, 3rd edn. New York: Cambridge University Press, 2009.
  • 4
    Citrome L, Jaffe A, Levine J. Dosing of second generation antipsychotic medication in a state hospital system. J Clin Psychopharmacol 2005;25:388390.
  • 5
    Cutler A, Ball S, Stahl SM. Dosing atypical antipsychotics. CNS Spectr 2008;9:116.
  • 6
    Schwartz T, Stahl SM. Treatment strategies for dosing the second generation antipsychotics. CNS Neurosci Ther. In press.
  • 7
    Mrazek DA. Psychiatric pharmacogenomics. New York: Oxford University Press, 2010.
  • 8
    Stahl SM. Personalized medicine, pharmacogenomics, and the practice of psychiatry: on the threshold of predictive therapeutics in psychopharmacology? CNS Spectr 2008;13:115118.